Madrigal Pharmaceuticals, Inc. MDGL Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Gross To Net Adjustments Reserve by Product | ||||||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $40.02M+69.0% | $23.68M+24.4% | $19.03M— | —— | —— | |
| Provision related to sales in the current year by Product | ||||||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $69.23M+88.9% | $36.64M+58.5% | $23.12M+54.6% | $14.95M+32.7% | $11.27M+40.1% | |
| Gross To Net Adjustments Reserve Credits And Payments Made by Product | ||||||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | $50.4M+65.7% | $30.42M+61.1% | $18.88M+62.4% | $11.63M+72.1% | $6.76M+75.2% | |
| Adjustments related to prior year sales by Product | ||||||
| Chargebacks, Discounts for Prompt Pay and Other Allowances | -$2.49M-58.0% | -$1.57M-19.2% | -$1.32M-15.9% | -$1.14M-6.8% | -$1.07M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Madrigal Pharmaceuticals, Inc. break its business down?
- Madrigal Pharmaceuticals, Inc. (MDGL) reports gross to net adjustments reserve by product across 2 parts — Chargebacks, Discounts for Prompt Pay and Other Allowances and Rebates, Co-Pay Assistance, Returns, and Other. Each is extracted from the segment footnotes and tracked over time.
- Where does Madrigal Pharmaceuticals, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Madrigal Pharmaceuticals, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
